Codexis to Report Third Quarter 2025 Financial Results on November 6
Codexis (NASDAQ: CDXS) will report third quarter 2025 financial results on Thursday, November 6, 2025, after market close. Management will host a conference call and live webcast at 4:30 PM Eastern Time to discuss results and provide a business update.
Investors can access the live webcast on the Codexis Investor Relations website; the webcast will be archived for 90 days. A telephone replay will be available for 48 hours with access ID 13726635.
Codexis (NASDAQ: CDXS) riferirà i risultati finanziari del terzo trimestre 2025 il giovedì 6 novembre 2025, dopo la chiusura del mercato. La direzione terrà una conference call e una trasmissione webcast in diretta alle 16:30 ora orientale per discutere i risultati e fornire un aggiornamento sull'attività.
Gli investitori possono accedere alla trasmissione webcast in diretta sul sito delle Relazioni con gli Investitori di Codexis; la webcast sarà archiviata per 90 giorni. Una registrazione telefonica sarà disponibile per 48 ore con ID di accesso 13726635.
Codexis (NASDAQ: CDXS) reportará los resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025, después del cierre del mercado. La dirección organizará una conferencia telefónica y una transmisión en vivo por webcast a las 4:30 p.m. hora del Este para discutir los resultados y proporcionar una actualización del negocio.
Los inversionistas pueden acceder a la transmisión en vivo por webcast en el sitio de Relaciones con Inversionistas de Codexis; la transmisión quedará archivada por 90 días. Una reproducción telefónica estará disponible durante 48 horas con el código de acceso 13726635.
Codexis (NASDAQ: CDXS)는 2025년 3분기 재무 실적을 2025년 11월 6일 목요일 장 마감 후 발표합니다. 경영진은 동부 표준시 4:30 PM에 컨퍼런스 콜과 생방송 웹캐스트를 개최하여 실적을 논의하고 비즈니스 업데이트를 제공할 예정입니다.
투자자들은 Codexis Investor Relations 웹사이트에서 생방송 웹캐스트에 접속할 수 있으며, 웹캐스트는 90일간 보관됩니다. 전화 재생은 48시간 동안 이용 가능하며 접근 ID는 13726635입니다.
Codexis (NASDAQ: CDXS) publiera les résultats financiers du troisième trimestre 2025 le jeudi 6 novembre 2025, après la clôture du marché. La direction animera une conférence téléphonique et une webdiffusion en direct à 16:30, heure de l’Est pour discuter des résultats et fournir une mise à jour sur l’activité.
Les investisseurs pourront accéder à la webdiffusion en direct sur le site des relations investisseurs de Codexis; la webdiffusion sera archivée pendant 90 jours. Une rediffusion téléphonique sera disponible pendant 48 heures avec l’identifiant d’accès 13726635.
Codexis (NASDAQ: CDXS) wird die Ergebnisse des dritten Quartals 2025 am Donnerstag, den 6. November 2025 nach Börsenschluss bekannt geben. Das Management wird eine Telefonkonferenz und einen Live-Webcast um 16:30 Uhr Eastern Time durchführen, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben.
Investoren können den Live-Webcast auf der Codexis Investor Relations-Website abrufen; der Webcast wird für 90 Tage archiviert. Eine telefonische Wiedergabe ist für 48 Stunden verfügbar, mit der Zugangs-ID 13726635.
Codexis (NASDAQ: CDXS) ستعلن عن نتائجها المالية للربع الثالث من 2025 يوم الخميس 6 نوفمبر 2025، بعد إغلاق السوق. ستترأس الإدارة مكالمة مؤتمرات وافتتاح بث مباشر عبر الويب في الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة لمناقشة النتائج وتقديم تحديث عن الأعمال.
يمكن للمستثمرين الوصول إلى البث المباشر عبر موقع علاقات المستثمرين لCodexis؛ وسيتم حفظ البث لمدة 90 يوماً. كما سيكون هناك إعادة تشغيل هاتفي متاح لمدة 48 ساعة مع معرف الدخول 13726635.
Codexis (NASDAQ: CDXS) 将在 2025年11月6日星期四，市场收盘后公布2025年第三季度财务业绩。管理层将于 美国东部时间16:30 举行电话会议和现场网络广播，以讨论业绩并提供业务更新。
投资者可以在 Codexis 投资者关系网站 获得现场网络广播；网络广播将保留 90天。电话回放将提供 48小时，访问ID 为 13726635。
- None.
- None.
REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the third quarter of 2025 on Thursday, November 6, 2025, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update.
Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international). A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Georgia Erbez
Chief Financial Officer
Codexis, Inc.
(650) 421-8100
ir@codexis.com
FAQ
When will Codexis (CDXS) report Q3 2025 results?
What time is the Codexis Q3 2025 earnings call and webcast?
How can I access the Codexis (CDXS) live webcast for Q3 2025?
What are the telephone numbers and replay details for the Codexis Q3 2025 call?
Will Codexis management provide a business update on the Q3 2025 call?
Where will the Codexis Q3 2025 webcast be archived and for how long?
